ennov1 (previously MyCancerDB's) founding members are also its first customers. They are late-stage cancer patients with the goal of using their fundamental health data -- including the raw sequence data for their whole healthy genomes, whole cancer genomes, and microbiomes -- to eliminate cancers and to achieve optimum health and wellness. We envision a world where all people dealing with incurable cancers are able to leverage their health data to quickly identify the best available, personalized treatment options.
ennov1 answers the compelling need for patients to be able to own, store, and gain control over their fundamental health data in a way that enables and empowers useful analysis and collaboration.
Company Details
- Founded
- -
- Address
- Stockbridge, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ennov1.com/
- Keywords
- bioinformatics, cancer support, healthcare innovation, healthcare navigation, genomics, genetics, sequencing, personalized medicine, cancer community, genomic analysis, AI technology, Targeted Cancer Therapy, Patient Empowerment, Data Portability, Collaborative Care.
- HQ
- Stockbridge
Ennov1 Questions
Ennov1's website is https://ennov1.com/
Ennov1's LinkedIn profile is https://www.linkedin.com/company/ennov1
Ennov1's industry is
Biotechnology Research
Ennov1's top competitors are
Epic,
Anthos Capital,
Hold Brothers Capital, Llc,
Nord Bio,
Cancerhacker Lab,
Stoke Space.
Ennov1's categories are Biotechnology Research
Ennov1's founding year is 2019
